×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Hansa Biopharma AB (publ) (STO:HNSA) Looks Just Right With A 32% Price Jump
Simply Wall Street
Hansa Biopharma AB (publ) ( STO:HNSA ) shares have had a really impressive month, gaining 32% after a shaky period...
6 days ago
Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting
FOX40
LUND, Sweden , May 21, 2024 /PRNewswire/ --. Hansa Biopharma, "Hansa" (NASDAQ: HNSA) (STOCKHOLM: HNSA), today announced data featuring...
6 days ago
Hansa Biopharma To Raises $34.5M Through Directed Issue
Law360
Hansa Biopharma AB said Friday that it plans to raise 372 million Swedish kronor ($35 million) through selling shares to institutional...
1 month ago
White & Case advises placing agents on Hansa Biopharma's directed share issue
White & Case LLP
Global law firm White & Case LLP has advised William Blair & Company, L.L.C. and Carnegie Investment Bank AB on a directed share issue by...
1 month ago
Some Analysts Just Cut Their Hansa Biopharma AB (publ) (STO:HNSA) Estimates
Simply Wall Street
One thing we could say about the analysts on Hansa Biopharma AB (publ) ( STO:HNSA ) - they aren't optimistic, having...
1 month ago
Hansa Biopharma closes enrolment in Phase ll trial of imlifidase in GBS
Clinical Trials Arena
Hansa Biopharma has concluded enrolling patients in its Phase ll trial of imlifidase for the treatment of Guillain-Barré Syndrome (GBS).
13 months ago
Analyst Estimates: Here's What Brokers Think Of Hansa Biopharma AB (publ) (STO:HNSA) After Its Yearly Report
Simply Wall Street
It's been a pretty great week for Hansa Biopharma AB (publ) ( STO:HNSA ) shareholders, with its shares surging 12% to...
3 months ago
Søren Tulstrup appointed new President and CEO of Hansa Medical
Cision News
Hansa Medical AB (Nasdaq Stockholm: HMED), a biopharmaceutical company developing novel immunomodulatory enzymes, today announced that the...
74 months ago
Global Roundup: Sputnik V Adapted, AB Science Submits ALS Drug in EU and More
BioSpace
Russian researchers announced a new Sputnik V vaccine against the Delta and Omicron variants of COVID-19, AB Science files for conditional...
21 months ago
Painful week for individual investors invested in Hansa Biopharma AB (publ) (STO:HNSA) after 10% drop, institutions also suffered losses
Simply Wall Street
Key Insights Significant control over Hansa Biopharma by individual investors implies that the general public has more...
2 months ago